发明名称 |
Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor through administration of a pyrophosphate analog |
摘要 |
Methods and compositions for increasing the efficacy of an agent that directly or indirectly affects a muscarinic receptor by administering a pyrophosphate analog. Methods and compositions for protecting a pharmacological agent in a formulation, comprising combining the pharmacological agent with at least one pyrophosphate analog. Methods and compositions for increasing the efficacy of a neurologic agent by administering at least one pyrophosphate analog. Methods and compositions for increasing the efficacy of an agent that neither directly nor indirectly affects a muscarinic receptor by administering at least one pyrophosphate analog. |
申请公布号 |
US9072756(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US200511220222 |
申请日期 |
2005.09.06 |
申请人 |
HealthPartners Research Foundation |
发明人 |
Frey, II William H.;Fawcett John Randall |
分类号 |
A61K31/70;A61K31/6615;A61K31/352;A61K31/409;A61K31/66;A61K31/661;A61K31/662;A61K31/663;A61K31/7072;A61K31/7076;A61K31/708;A61K31/7084;A61K31/7105;A61K45/06 |
主分类号 |
A61K31/70 |
代理机构 |
Winthrop & Weinstine, P.A. |
代理人 |
Winthrop & Weinstine, P.A. |
主权项 |
1. A method for increasing the efficacy of an agent that inhibits acetylcholinesterase in a subject suffering from Alzheimer's disease, comprising:
delivering an effective amount of pamidronate to a subject suffering from Alzheimer's disease that is concurrently receiving, has recently received, or will soon receive an agent that inhibits acetylcholinesterase; and increasing the efficacy of the agent that inhibits acetylcholinesterase in the subject in need thereof; wherein the effective amount of pamidronate is intranasally administered to the upper one third of the subject's nasal cavity, thereby enabling the pamidronate to bypass the subject's blood-brain barrier. |
地址 |
Bloomington MN US |